作者: Yong-Zhan Zhen , Na-Ren Li , Hong-Wei He , Shuang-Shuang Zhao , Guang-Ling Zhang
关键词: Drug 、 Biology 、 Pathology 、 Bile duct ligation 、 Hepatic fibrosis 、 Liver fibrosis 、 Cholestatic liver disease 、 Gene expression
摘要: CONCLUSION: Bicyclol significantly attenuates BDL-induced liver fibrosis by reversing fibrogenic gene expression. These findings suggest that bicyclol might be an effective anti-fibrotic drug for the treatment of cholestatic disease.